IL17A and atherosclerosis: Moreover, IL-27R deficiency in hematopoietic cells led to accelerated disease progression in Ldlr−/− mice, in particular via upregulated IL-17A production by CD4+ T cells19, thereby illuminating an important role of IL-27R signaling in controlling of adaptive immunity in atherosclerosis.